GAITHERSBURG, Md., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today reports that it received formal notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) that it is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of the Compa ...

NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of August 15, 2024, short interest in 3,037 Nasdaq Global MarketSM securities totaled 12,277,781,936 shares compared with 11,985,723,964 shares in 3,043 Global Market issues reported for the prior settlement date of July 31, 2024. The mid-August short interest represents 2.62 days compared with 2.90 days for the prior reporting period. Short interest in 1,669 securities on The Nasdaq Capital MarketSM totaled 2,136,281,640 shares a ...

Company today has become a corporation renamed “Capital Clean Energy Carriers Corp.” (“CCEC”), emphasizing the company’s strategic pivot to the LNG and energy transition businessUpon delivery of all contracted for vessels by 3Q27, CCEC expects to become the largest U.S.-listed LNG transportation company and well-positioned for future growth ATHENS, Greece, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Capital Clean Energy Carriers Corp. (“CCEC”, “we” or “us”) (NASDAQ: CCEC), an international owner of ocean-going vessel ...

Singapore, Aug. 26, 2024 (GLOBE NEWSWIRE) -- noco-noco Inc (the "Company”) received a hearing decision letter (the “Decision Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”). The Decision Letter gave the Company an exception period until October 30, 2024 to regain compliance with Listing Rule 5550(a)(2) (the “Bid Price Rule”) and Listing Rule 5550(b)(2) (the “MVLS Rule”) or any of the alternatives outlined in Listing Rule 5550(b). Accordingly, the Nasdaq Hearings ...

Investors looking for exposure to Bitcoin might want to check out this exchange-traded fund.The stock market has held up quite well so far in 2024. Developments such as weight loss drugs and artificial intelligence (AI) have helped fuel the S&P 500 and Nasdaq Composite to new highs.But in the background, alternative investments such as crypto have demonstrated some strength as well. In particular, Bitcoin is up 41% so far in 2024.I understand if you don't have the appetite to invest directly in crypto, thou ...

The dividend yields for these stocks are tempting. But some temptations should be avoided.What comes to mind when I mention Nasdaq stocks? I doubt many thought of ultra-high-yield dividend stocks. On the other hand, I suspect high-flying tech stocks were front and center in the thoughts of many readers.The reality, though, is that the Nasdaq is chock-full of both high-flying tech stocks and stocks that offer exceptionally juicy dividends. Should you buy the three highest-paying dividend stocks in the Nasdaq ...

SAN DIEGO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that on August 22, 2024, the Board of Directors granted a non-qualified stock option award to purchase 40,000 shares of its common stock to one new non-executive employee under the Company’s 2024 Inducement Equity Incentive Plan (the “2024 Inducement Plan”). The stock options were granted as ...

FLORHAM PARK, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that the Company had received an expected delinquency notification letter (the “Notice”) from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) on August 20, 2024. The Notice indicated that the Company is not in compliance wit ...

BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) advising that, because the Company failed to timely file its Quarterly Report on Form 10-Q for the fiscal ...

BEIJING, Aug. 23, 2024 /PRNewswire/ -- China Liberal Education Holdings Limited (Nasdaq: CLEU) ("China Liberal", the "Company", "we", "our", or "us"), a China-based company that provides smart campus solutions and other educational services, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on August 21, 2024, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq ...